This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

DiaDexus, Inc. Reports First Quarter 2013 Financial Results

SOUTH SAN FRANCISCO, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the first quarter ended March 31, 2013.

Brian Ward, Ph.D., diaDexus' President and Chief Executive Officer, said, "diaDexus had a strong first quarter 2013, delivering our 11 th consecutive quarter of year-over-year revenue growth while making investments in our commercial operations and product development to support our long-term growth ambitions. These included the addition of new sales representatives in targeted geographies and increased focus on the development of our new product pipeline. We also continued to drive expanded reimbursement for the PLAC Test, which should help to reduce pricing pressure and have a positive impact on our cardiovascular specialty laboratory partners."

Total revenues for the first quarter 2013 were $5.6 million, a 12% increase over $4.9 million reported in the first quarter 2012. Demand for the PLAC Test remained strong with volume increases outpacing pricing pressure. As a result, gross margins in the first quarter 2013 improved to 67% compared to 65% for the same quarter in 2012. Total operating expenses for the quarter were $6.9 million, compared to $6.2 million for the first quarter 2012. The increase in operating expenses was the result of increased investments in sales and marketing in the first quarter 2013 compared to the same quarter in 2012, partially offset by lower research and development costs. General and administrative expenses were flat in the first quarter 2013 compared to the same period in 2012. The Company's net loss for the first quarter 2013 narrowed to $1.2 million, or $(0.02) per share, from a net loss of $1.3 million, or $(0.02) per share, in the first quarter 2012.

Cash and cash equivalents and investments at March 31, 2013 were $13.0 million compared to $13.6 million at December 31, 2012.

Stock quotes in this article: DDXS 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,398.74 -26.11 -0.16%
S&P 500 1,862.31 0.00 0.00%
NASDAQ 4,087.9240 +1.6990 0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs